QF
CLVS

QVT Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

QVT Financial’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600,000
Closed -$1.08M – 65
2022
Q2 		$1.08M Buy
600,000
+100,000
+20% +$148K 0.07% 52
2022
Q1 		$1.01M Buy
+500,000
New +$982K 0.04% 59

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

QVT Financial's CLVS Position: Q4 2022 in Review

QVT Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 3,525,000 shares — an estimated $4.2M sold.

QVT Financial first reported a position in CLVS in Q2 2013 and held it in 9 quarters. The position peaked at $41.4M in Q2 2013. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • QVT Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • QVT Financial sold 3,525,000 Clovis Oncology, Inc. shares in Q4 2022, an estimated $4.2M.
  • QVT Financial first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 9 quarters.
  • QVT Financial's Clovis Oncology, Inc. position peaked at $41.4M in Q2 2013.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on QVT Financial's 13F filing for Q4 2022, filed 14 Feb 2023.